|
|||||
|
|
The time-varying cardiovascular benefits of glucagon-like peptide-1 receptor agonist therapy in patients with type 2 diabetes mellitus: Evidence from large multinational trials |
|
| Authors: | Salil V. Deo MD Shayan Marsia MBBS David A. McAllister MD Yakov Elgudin MD Naveed Sattar MD Jill P. Pell MD |
| Affiliation: | 1. Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK;2. Department of Internal Medicine, Dow Medical College, Karachi, Pakistan;3. Surgical Services, Louis Stokes Cleveland VA Medical Center, Cleveland, Ohio, USA Case School of Medicine, Case Western Reserve University, Cleveland, Ohio, USA;4. Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK |
| Abstract: | |
| Keywords: | cardiovascular outcomes trials clinical trials GLP receptor agonist systematic review type II diabetes mellitus |